David O. Sussman, DO, FACOS, is clinical associate professor, Department of Surgery, Division of Urology, and section head of Female Urology and Voiding Dysfunction at Rowan University in Glassboro, New Jersey. He is chief of urology for Jefferson New Jersey, a 3-hospital health system in southern New Jersey. Dr Sussman is actively engaged in clinical research involving BPH, urinary incontinence and voiding dysfunction. He has served as a speaker, moderator and symposium chairman for many major urology symposia, seminars and conferences, lectured nationally and internationally on the evaluation/treatment of OAB/incontinence, and has authored or co-authored several journal articles, posters and abstracts. He received his medical degree from the University of New England in Biddeford, Maine.

Jennifer U. Miles-Thomas, MD, FPMRS, is the medical director of the Pelvic Health program at Chesapeake Regional Healthcare in Virginia Beach, Virginia, and is assistant professor of urology at Eastern Virginia Medical School. Dr Miles-Thomas provides specialized care in female reconstructive surgery, pelvic prolapse, incontinence, complicated urinary disorders, and disorders of the urinary system due to neurologic disease. She earned her medical degree from Northwestern University Feinberg School of Medicine in Chicago, Illinois and completed a general surgery internship at the Johns Hopkins Hospital in Baltimore, Maryland, where she also completed her urology residency and fellowships in female urology and endourology at the James Buchanan Brady Urological Institute.

Scott A. MacDiarmid, MD, is director of the Alliance Urology Specialists Bladder Control and Pelvic Pain Center in Greensboro, North Carolina, and is a clinical professor in the Department of Urology, University of North Carolina, Chapel Hill. Dr MacDiarmid’s clinical, educational and academic expertise is in male and female voiding dysfunction, neurogenic bladder, and complex lower urinary tract and pelvic floor reconstruction. He has authored or co-authored numerous books, book chapters and journal articles, and is recognized nationwide as a leader in his field. He completed fellowships in reconstructive urology and urodynamics at Duke University Medical Center in Durham, North Carolina, the University of Otago in Christchurch, New Zealand, and the University of Sheffield in England.

Neal D. Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr Shore has conducted more than 250 clinical trials that focus mainly on GU oncology, serves on the executive boards of the Society of Urologic Oncology, Bladder Cancer Advocacy Network and the Society of Urologic Oncology Clinical Trials Consortium, and is president of the Large Urology Group Practice Association. He is a founder for the CUSP Clinical Trials Consortium and DASHKO, large urology practices data registries. He has over 125 peer-reviewed publications, several book chapters, and is a peer reviewer for Lancet Oncology, Urology, and numerous other journals. He earned his MD from Duke University Medical School.

Mara R. Holton, MD, is the CEO of Anne Arundel Urology group in Annapolis, Maryland. Board-certified by the American Board of Urology and licensed in the state of Maryland, Dr Holton is clinically focused on the care of women’s urological and pelvic floor health. She is the founder and director of the Women’s Wellness Center at Anne Arundel Urology, and is a member of the American Urological Association and the Large Urology Group Practice Association. Dr Holton received her medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania, and completed her surgical and urology training at the University of Maryland Medical Center in Baltimore.

Britt McDermott is the chief executive officer for Urology of Indiana in Greenwood, where she has served in her current role since 2015. Prior to joining Urology of Indiana, she served as the vice president of Indiana operations for a large multispecialty group. In addition to her health care leadership experience, she has spent more than 20 years providing accounting, tax and consulting services exclusively to health care providers. Ms McDermott is a graduate of Indiana University, Bloomington, and is a certified public accountant.

Earl L. Walz is chief executive officer of The Urology Group in Cincinnati, Ohio. Prior to joining The Urology Group, he was chief operating officer of the Urology Specialists, served as chief administrative consultant at the Northern Kentucky Multi Specialty Practice, and was chief operating officer of the Hoxworth Blood Center in Cincinnati. A certified medical practice executive, he is a member of several corporate and government medical advisory boards, and is a co-founder of the Large Urology Group Practice Association. He received his master’s degree in business administration from Xavier University in Cincinnati and a bachelor of science degree from the Northern Kentucky University in Highland Heights.

Twila Puritty, MBA, is the chief executive officer of Wichita Urology Group in Wichita, Kansas. Having more than 25 years of experience in health care leadership, Mrs Puritty’s professional passions are facilitating growth initiatives, enhancing collection efforts through microanalysis and maximizing shareholder wealth. In her 5 years with Wichita Urology Group, the practice has grown by building a free-standing radiation oncology facility, adding a successful clinical trial program, implementing Xofigo infusions and in-office dispensing, and developing successful equipment and building leasing LLCs. Prior to joining Wichita Urology Group, Mrs Puritty served as the lead nonphysician executive for radiology groups in Florida, California, Oklahoma, Nebraska and Kansas.

David Chaikin, MD, is an urologist with Garden State Urology in Whippany, New Jersey, specializing in urogynecology and female reconstructive pelvic medicine, and male voiding dysfunction. He received his medical degree from the Albert Einstein College of Medicine in Bronx, New York, and completed his general surgery fellowship and urology residency at the Hospital of the University of Pennsylvania in Philadelphia. He is affiliated with Morristown Medical Center in Morristown, New Jersey and Weill Cornell Medical College in New York. Dr Chaikin’s specific areas of interest are urogynecology, male and female incontinence, genital prolapse, and neurologic disorders affecting the bladder.

Michael D. Fabrizio, MD, FACS, is the CEO of Urology of Virginia, as well as professor of urology and endourology fellowship director at Eastern Virginia Medical School in Virginia Beach. Dr Fabrizio specializes in urological laparoscopy for benign and malignant conditions, including prostate and kidney cancer, adrenal surgery, kidney donation, and complex kidney and ureteral stone surgery. He is currently president-elect of the Mid-Atlantic Section of the American Urological Association, and a member of the American Urological Association, Endourology Society, and the Society of Urologic Oncology. He earned his medical degree from the Medical College of Virginia, and completed his residencies in surgery and urology at the Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.

Bryan A. Mehlhaff, MD, is currently an urologist in private practice at Oregon Urology Institute in Springfield, where he also serves as the research medical director. Prior to joining Oregon Urology Institute, Dr Mehlhaff was an assistant professor of surgery in the division of urology at Albany Medical College in Albany, New York, where he honed his skills in adult and pediatric urology, endourology, and minimally invasive surgery. He serves on multiple urologic medical advisory boards and is a board member of the Large Urology Practice Association (LUGPA). Dr Mehlhaff has an active and ongoing interest in the latest therapeutics in advanced prostate cancer. He earned his medical degree from Oregon Health Sciences University, School of Medicine, in Portland.

Paul R. Sieber, MD, is a practicing urologist based in Lancaster, Pennsylvania, and currently serves as president and the medical director of research for Lancaster Urology. Dr Sieber, who focuses primarily on prostate cancer, serves as the principal investigator for all of the clinical trials at Lancaster Urology. Having served as a principal investigator in more than 200 trials, he is enthusiastic about clinical trials and research as he looks at what can benefit his patients in the future. Dr Sieber earned his medical degree from the Indiana University-Purdue University at Indianapolis.

Bob Asinof is the CEO of the Urology Center of Colorado in Denver. Mr Asinof has been the administrator of the group since 1992, and has 30 years of experience in the health care industry in hospital finance and physician group practice management. He currently also serves as treasurer of the Large Urology Group Practice Association (LUGPA), is a member of the Healthcare Financial Management Association as well as the Medical Group Management Association. He earned his Master of Science degree in health administration from the University of Colorado in Denver.